Fe3O4@mSiO2 core–shell nanocomposite capped with disulfide gatekeepers for enzyme-sensitive controlled release of anti-cancer drugs

2015 ◽  
Vol 3 (6) ◽  
pp. 1010-1019 ◽  
Author(s):  
Chunyu Yang ◽  
Wei Guo ◽  
Liru Cui ◽  
Na An ◽  
Ting Zhang ◽  
...  

Multifunctional nanocarriers based on the magnetic Fe3O4 nanoparticle core and bis-(3-carboxy-4-hydroxy phenyl) disulfide modified mesoporous silica shell were synthesized for cancer treatment through passive targeting and enzyme-sensitive drug release.

RSC Advances ◽  
2021 ◽  
Vol 11 (48) ◽  
pp. 29986-29996
Author(s):  
Xiuxiu Qi ◽  
Hongmei Yan ◽  
Yingxue Li

A pH-sensitive core–shell nanoparticle (HMS@C18@PSDMA-b-POEGMA) was developed via a self-assembly process as the carrier of anticancer drug doxorubicin (DOX) for drug loading and controlled release.


2019 ◽  
Vol 55 (61) ◽  
pp. 9039-9042 ◽  
Author(s):  
Andy Hernández-Montoto ◽  
Mónica Gorbe ◽  
Antoni Llopis-Lorente ◽  
José Manuel Terrés ◽  
Roberto Montes ◽  
...  

Gold nanostars coated with a mesoporous silica shell and functionalised with PEG containing photolabile 2-nitrobenzyl moieties released doxorubicin after NIR light irradiation.


Nano Research ◽  
2019 ◽  
Vol 12 (5) ◽  
pp. 999-1008 ◽  
Author(s):  
Yongjuan Li ◽  
Jian Hu ◽  
Xun Liu ◽  
Yong Liu ◽  
Shixian Lv ◽  
...  

Pharmaceutics ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 432 ◽  
Author(s):  
Rafael R. Castillo ◽  
Daniel Lozano ◽  
María Vallet-Regí

The enormous versatility of mesoporous silica nanoparticles permits the creation of a large number of nanotherapeutic systems for the treatment of cancer and many other pathologies. In addition to the controlled release of small drugs, these materials allow a broad number of molecules of a very different nature and sizes. In this review, we focus on biogenic species with therapeutic abilities (proteins, peptides, nucleic acids, and glycans), as well as how nanotechnology, in particular silica-based materials, can help in establishing new and more efficient routes for their administration. Indeed, since the applicability of those combinations of mesoporous silica with bio(macro)molecules goes beyond cancer treatment, we address a classification based on the type of therapeutic action. Likewise, as illustrative content, we highlight the most typical issues and problems found in the preparation of those hybrid nanotherapeutic materials.


RSC Advances ◽  
2017 ◽  
Vol 7 (38) ◽  
pp. 23342-23347 ◽  
Author(s):  
Mark A. Isaacs ◽  
Lee J. Durndell ◽  
Anthony C. Hilton ◽  
Luca Olivi ◽  
Christopher M. A. Parlett ◽  
...  

Silica encapsulated silver nanoparticle core–shell nanocomposites of tunable dimensions were synthesised via a one-pot reverse microemulsion route to achieve controlled release of Ag+ ions for broad spectrum antibacterial application.


2019 ◽  
Vol 7 (7) ◽  
pp. 1050-1055 ◽  
Author(s):  
Liangcan He ◽  
Kanglei Pang ◽  
Wenwen Liu ◽  
Yue Tian ◽  
Lin Chang ◽  
...  

Core–shell Au@zeolitic-imidazolate-framework nanocarriers with high drug-loading, controlled drug release properties, and high cancer treatment efficiency.


RSC Advances ◽  
2020 ◽  
Vol 10 (44) ◽  
pp. 26504-26507
Author(s):  
Darius Rohleder ◽  
Philipp Vana

A green approach: in a single-step coating process a mesoporous silica shell was tailored onto palladium-nanocubes. Along with a PEG-matrix this core–shell-nanocatalyst could be recovered after C–C-coupling reactions and reused without any significant decrease in product yield.


Sign in / Sign up

Export Citation Format

Share Document